Penetration of cefazolin into normal and osteomyelitic canine cortical bone

R. C. Daly, R. H. Fitzgerald, J. A. Washington

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The ability of cefazolin to cross the capillary membranes and its concentrations in the interstitial fluid spaces were studied in normal and osteomyelitic canine bone. The maximum extraction after a single capillary passage and the net extraction after 3 min, determined with triple-tracer indicator-dilution techniques, demonstrated that cefazolin readily traversed the capillaries of normal and osteomyelitic bone. These studies suggest that the altered pathophysiology of osteomyelitic tissue and the complex diffusional characteristics of enhanced emhanced the ability of this agent to cross the endothelial cells lining the capillaries of osteomyelitic bone. Volume of distribution studies demonstrated that cefazolin was distributed in the plasma and interstitial fluid spaces of normal cortical bone. Although these spaces were increased 330 and 941% in osteomyelitic tissue, the distribution of cefazolin increased proportionally. There was a direct correlation between the calculated concentrations of cefazolin in the interstitial fluid spaces of normal and osteomyelitis cortical bone and the simultaneous serum levels in animals in which a steady-state equilibrium had been achieved. These studies suggest that a physiological barrier or concentration gradient for cefazolin does not exist in normal or osteomyelitic bone. Cefazolin can cross the capillary membranes of bone and achieve bactericidal concentrations in the interstitial fluid space of normal and osteomyelitic tissue.

Original languageEnglish (US)
Pages (from-to)461-469
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume22
Issue number3
StatePublished - 1982

Fingerprint

Cefazolin
Canidae
Extracellular Fluid
Bone and Bones
Indicator Dilution Techniques
Membranes
Tissue Distribution
Osteomyelitis
Cortical Bone
Endothelial Cells
Serum

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Daly, R. C., Fitzgerald, R. H., & Washington, J. A. (1982). Penetration of cefazolin into normal and osteomyelitic canine cortical bone. Antimicrobial Agents and Chemotherapy, 22(3), 461-469.

Penetration of cefazolin into normal and osteomyelitic canine cortical bone. / Daly, R. C.; Fitzgerald, R. H.; Washington, J. A.

In: Antimicrobial Agents and Chemotherapy, Vol. 22, No. 3, 1982, p. 461-469.

Research output: Contribution to journalArticle

Daly, RC, Fitzgerald, RH & Washington, JA 1982, 'Penetration of cefazolin into normal and osteomyelitic canine cortical bone', Antimicrobial Agents and Chemotherapy, vol. 22, no. 3, pp. 461-469.
Daly, R. C. ; Fitzgerald, R. H. ; Washington, J. A. / Penetration of cefazolin into normal and osteomyelitic canine cortical bone. In: Antimicrobial Agents and Chemotherapy. 1982 ; Vol. 22, No. 3. pp. 461-469.
@article{1eaba76cae49478ba5fba64fe0e30c8b,
title = "Penetration of cefazolin into normal and osteomyelitic canine cortical bone",
abstract = "The ability of cefazolin to cross the capillary membranes and its concentrations in the interstitial fluid spaces were studied in normal and osteomyelitic canine bone. The maximum extraction after a single capillary passage and the net extraction after 3 min, determined with triple-tracer indicator-dilution techniques, demonstrated that cefazolin readily traversed the capillaries of normal and osteomyelitic bone. These studies suggest that the altered pathophysiology of osteomyelitic tissue and the complex diffusional characteristics of enhanced emhanced the ability of this agent to cross the endothelial cells lining the capillaries of osteomyelitic bone. Volume of distribution studies demonstrated that cefazolin was distributed in the plasma and interstitial fluid spaces of normal cortical bone. Although these spaces were increased 330 and 941{\%} in osteomyelitic tissue, the distribution of cefazolin increased proportionally. There was a direct correlation between the calculated concentrations of cefazolin in the interstitial fluid spaces of normal and osteomyelitis cortical bone and the simultaneous serum levels in animals in which a steady-state equilibrium had been achieved. These studies suggest that a physiological barrier or concentration gradient for cefazolin does not exist in normal or osteomyelitic bone. Cefazolin can cross the capillary membranes of bone and achieve bactericidal concentrations in the interstitial fluid space of normal and osteomyelitic tissue.",
author = "Daly, {R. C.} and Fitzgerald, {R. H.} and Washington, {J. A.}",
year = "1982",
language = "English (US)",
volume = "22",
pages = "461--469",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Penetration of cefazolin into normal and osteomyelitic canine cortical bone

AU - Daly, R. C.

AU - Fitzgerald, R. H.

AU - Washington, J. A.

PY - 1982

Y1 - 1982

N2 - The ability of cefazolin to cross the capillary membranes and its concentrations in the interstitial fluid spaces were studied in normal and osteomyelitic canine bone. The maximum extraction after a single capillary passage and the net extraction after 3 min, determined with triple-tracer indicator-dilution techniques, demonstrated that cefazolin readily traversed the capillaries of normal and osteomyelitic bone. These studies suggest that the altered pathophysiology of osteomyelitic tissue and the complex diffusional characteristics of enhanced emhanced the ability of this agent to cross the endothelial cells lining the capillaries of osteomyelitic bone. Volume of distribution studies demonstrated that cefazolin was distributed in the plasma and interstitial fluid spaces of normal cortical bone. Although these spaces were increased 330 and 941% in osteomyelitic tissue, the distribution of cefazolin increased proportionally. There was a direct correlation between the calculated concentrations of cefazolin in the interstitial fluid spaces of normal and osteomyelitis cortical bone and the simultaneous serum levels in animals in which a steady-state equilibrium had been achieved. These studies suggest that a physiological barrier or concentration gradient for cefazolin does not exist in normal or osteomyelitic bone. Cefazolin can cross the capillary membranes of bone and achieve bactericidal concentrations in the interstitial fluid space of normal and osteomyelitic tissue.

AB - The ability of cefazolin to cross the capillary membranes and its concentrations in the interstitial fluid spaces were studied in normal and osteomyelitic canine bone. The maximum extraction after a single capillary passage and the net extraction after 3 min, determined with triple-tracer indicator-dilution techniques, demonstrated that cefazolin readily traversed the capillaries of normal and osteomyelitic bone. These studies suggest that the altered pathophysiology of osteomyelitic tissue and the complex diffusional characteristics of enhanced emhanced the ability of this agent to cross the endothelial cells lining the capillaries of osteomyelitic bone. Volume of distribution studies demonstrated that cefazolin was distributed in the plasma and interstitial fluid spaces of normal cortical bone. Although these spaces were increased 330 and 941% in osteomyelitic tissue, the distribution of cefazolin increased proportionally. There was a direct correlation between the calculated concentrations of cefazolin in the interstitial fluid spaces of normal and osteomyelitis cortical bone and the simultaneous serum levels in animals in which a steady-state equilibrium had been achieved. These studies suggest that a physiological barrier or concentration gradient for cefazolin does not exist in normal or osteomyelitic bone. Cefazolin can cross the capillary membranes of bone and achieve bactericidal concentrations in the interstitial fluid space of normal and osteomyelitic tissue.

UR - http://www.scopus.com/inward/record.url?scp=0020384735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020384735&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 461

EP - 469

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -